A recent collaborative study between the U.S. Army Medical Research Institute of Infectious Diseases, National Institutes of Health's Vaccine Research Center, U.S. Naval Research Laboratory, and the Frederick National Laboratory for Cancer Research has identified two promising single-domain antibodies (sdAbs) that may offer a therapeutic option against multiple subtypes of Venezuelan equine encephalitis virus (VEEV).
USAMRIID Collective Study Demonstrates Potential Broad-Spectrum Anti-Alphavirus Therapeutics
